the Group.
GROUP AT  
GROUP
GROUP
the Group through 
• In FY2016, the Group was awarded 
This is the Group’s 
• The Group continues to pursue new 
The Group’s 
The Group 
ACROSS THE GROUP
4 4 Following on from the award, in FY2016, of the Group’s first drug and device development and 
In the current year, the Group’s conversion of operating profit into cash inflows reduced to 83%.
4 4 Following on from the award, in FY2016, of the Group’s first drug and device development and 
In the current year, the Group’s conversion of operating profit into cash inflows reduced to 83%.
EPS enhancement – the Group reviews EPS from continuing operations before 
EPS enhancement – the Group reviews EPS from continuing operations before 
• Continue to recruit and develop apprentices across the Group.
• Ensure mentoring is embedded Group-wide and employees at all levels have an opportunity to benefit 
The Group has 
During the year the Group has reviewed 
The Group’s  
Group
the Group by 
However, the Group 
progressive review of the risk register that could materially affect the Group’s ability to achieve its financial and operating 
Group plc as a non-executive director in 
Chief Executive Jonathan Glenn • Developing Group strategy for consideration and 
• reports from the Chief Executive and CFO on the Group’s 
of the Group.
Group and developing a risk management strategy; ensuring 
the Board, the Group’s financial and reporting practices and 
Group
operation of the Group’s business.
• The 2017 awards under the Performance Share Plan will 
• EBIT margin improvement – the Group delivered improved 
Group 0%
Group 100%
in the Group.
the Group.
THE GROUP
the Group.
The Group operates share option schemes, performance-
and the Group and parent company financial statements in 
Company law requires the directors to prepare Group and 
preparing each of the Group and parent company financial 
Managers of the Group’s Bespak and Aesica businesses 
Executive Committee focuses on the operations of the Group 
The Group 
to the Group.
The Group operates a number of equity-settled, share-based 
Group:
with the Group financial statements, the Company is taking 
The Group’s total non-current assets in the current year attributable to the United Kingdom are £318.9m (FY2016: £320.2m) and 
Group
Group
• A special tax item of £1.1m was recognised in the prior year as a result of the recognition of deferred tax on capital losses 
• A special tax item of £1.0m was recognised in the prior year as a capital allowance review was carried out in that year which 
• A special tax item of £0.4m (2016: £0.5m) was recognised as the impact of a number of prior year adjustments made.
• A special tax item of £0.5m (2016: £1.1m) arises in respect of a significant tax credit as the Group’s deferred tax assets and 
Group Company 
Deferred tax assets in the Company are recognised on the basis that their reversal in the future will generate current year losses 
Group 
Group 
for each CGU are based on the Group’s strategic plan incorporating three years from FY2018 to FY2020 which was approved 
Group – equity investments
Group  Company 
Group  Company 
Group 
Group 
Group 
Group 
Group  Company 
Group  Company 
The balances due after more than one year in the Company are amounts payable to Group undertakings.
During the year, the Group operated four pension schemes: one in the UK, one in Italy and two in Germany.
The Group also operated three additional defined benefit pension schemes during the year, two of which were operated by 
The Group meets the full cost of accrual, but members receive a reduction in their salary equal to their share of 
The Group provides retirement benefits via the Bespak scheme to some of its former employees and approximately 30% 
Group
Group  Company 
Group 
Group and Company
the Group.
• Currency exchange contracts – based on market prices and exchange rates at the balance sheet date;
The Group uses a Euro loan, which had a carrying value of £29.6m at the year end (2016: 
However, the Group 
Group is exposed to credit-related losses in the event of non-performance by counterparties to financial instruments, but does 
The Group operates internationally, primarily through subsidiary companies established in the markets in which the Group 
Group  Company 
The following tables categorise the Group’s and Company’s financial assets and liabilities held at fair value by the valuation 
Group
Group and Company
The interest rate profile of the financial assets and liabilities of the Group at 30 April in the current and prior year is as follows:
Group  Company 
Group
from Group 
Group  Company 
Group
to Group 
Group  Company 
Group  Company 
The currency profile of the financial assets and liabilities of the Group and Company is as follows:
Group  Company 
Group  Company 
The Group operates share award schemes whereby awards are granted to employees to acquire shares in Consort Medical 
Share options awarded to the directors are subject to performance criteria as detailed in the Remuneration Report.
The Group operates performance share plans whereby awards are granted to directors and senior management at no cost.
The percentage of each award that vests is based upon the performance of the Group over a three-year measurement 
The Group operates a Deferred Bonus Plan whereby awards are granted to directors and senior management at no cost.
percentage of each award that vests is based upon the performance of the Group over a three-year measurement period.
Group  Company 
Group  Company 
• the financial statements give a true and fair view of the state of the Group’s and of the parent company’s affairs as at 
• the Group financial statements have been properly prepared in accordance with International Financial Reporting 
• the information given in the Strategic Report and the Directors’ Report for the financial year is consistent with the financial 
directors’ assessment and expectations of the Group’s continuing in operation over the three years to 2020; or 
• the parent company financial statements and the part of the Directors’ Remuneration Report to be audited are not in 